Cargando…

Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer

BACKGROUND: Nearly half of muscle-invasive bladder cancer patients succumb to their disease following cystectomy. Selecting candidates for adjuvant therapy is currently based on clinical parameters with limited predictive power. This study aimed to develop and validate genomic-based signatures that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitra, Anirban P., Lam, Lucia L., Ghadessi, Mercedeh, Erho, Nicholas, Vergara, Ismael A., Alshalalfa, Mohammed, Buerki, Christine, Haddad, Zaid, Sierocinski, Thomas, Triche, Timothy J., Skinner, Eila C., Davicioni, Elai, Daneshmand, Siamak, Black, Peter C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241889/ https://www.ncbi.nlm.nih.gov/pubmed/25344601 http://dx.doi.org/10.1093/jnci/dju290

Ejemplares similares

Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers
por: Vergara, Ismael A., et al.
Publicado: (2012)

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
por: Erho, Nicholas, et al.
Publicado: (2013)

Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer
por: Erho, Nicholas, et al.
Publicado: (2012)

Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group
por: Badani, Ketan, et al.
Publicado: (2013)

Evolving transcriptomic fingerprint based on genome‐wide data as prognostic tools in prostate cancer
por: Alshalalfa, Mohammed, et al.
Publicado: (2015)

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
por: Tsai, Harrison K., et al.
Publicado: (2017)

Surgical Clips Migration up to Renal Collecting System from Ileal Conduit Postcystectomy
por: Albadawi, Hani, et al.
Publicado: (2016)

The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
por: Prensner, John R., et al.
Publicado: (2013)

Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
por: Lee, Hak J, et al.
Publicado: (2016)

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
por: Stoyanova, Radka, et al.
Publicado: (2016)

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
por: Jäger, Wolfgang, et al.
Publicado: (2015)

The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer
por: Prensner, John R., et al.
Publicado: (2014)

Reprogramming of the human intestinal epigenome by surgical tissue transposition
por: Lay, Fides D., et al.
Publicado: (2014)

Development of a predictive model for stromal content in prostate cancer samples to improve signature performance
por: Boufaied, Nadia, et al.
Publicado: (2019)

The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
por: Chakravarty, Dimple, et al.
Publicado: (2014)

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma
por: Alshalalfa, Mohammed, et al.
Publicado: (2019)

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
por: Spans, Lien, et al.
Publicado: (2016)

Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy
por: Den, Robert B., et al.
Publicado: (2014)

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
por: Badani, Ketan K, et al.
Publicado: (2015)

A comparison of five methods for selecting tagging single-nucleotide polymorphisms
por: Burkett, Kelly M, et al.
Publicado: (2005)

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients
por: Alshalalfa, Mohammed, et al.
Publicado: (2017)

Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
por: Liu, Deli, et al.
Publicado: (2018)

Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancer
por: Berglund, Anders E., et al.
Publicado: (2018)

A Central Role for Long Non-Coding RNA in Cancer
por: Mitra, Sheetal A., et al.
Publicado: (2012)

Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy
por: Kiss, Bernhard, et al.
Publicado: (2017)

Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
por: Kim, Hyun, et al.
Publicado: (2016)

The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
por: Ramnarine, Varune Rohan, et al.
Publicado: (2018)

Adenomatous Polyp of the Verumontanum Causing Bladder Outlet Obstruction
por: Daneshmand, Siamak
Publicado: (2004)

Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases
por: Mitra, Anirban P., et al.
Publicado: (2022)

The Therapeutic Effectiveness of Risperidone on Negative Symptoms of Schizophrenia in Comparison with Haloperidol: A Randomized Clinical Trial
por: Mirabzadeh, Arash, et al.
Publicado: (2014)

Attention-Deficit/Hyperactivity Disorder and Martial Satisfaction: The Preliminary Roles of Employment and Income
por: Kachooei, Hamid, et al.
Publicado: (2016)

Prostate Cancer Tumor Volume and Genomic Risk
por: Ramaswamy, Ashwin, et al.
Publicado: (2023)

Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial
por: Tosco, Lorenzo, et al.
Publicado: (2018)

A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)
por: Ghadessi, Mercedeh, et al.
Publicado: (2020)

Inferring cancer subnetwork markers using density-constrained biclustering
por: Dao, Phuong, et al.
Publicado: (2010)

Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes
por: Ahmadi, Hamed, et al.
Publicado: (2014)

Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
por: Hu, Brian, et al.
Publicado: (2018)

Multiparametric cystoscopy: is the future here yet?
por: Ahmadi, Hamed, et al.
Publicado: (2021)

Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
por: Alsyouf, Muhannad, et al.
Publicado: (2023)

Women-only drug treatment services and needs in Iran: the first review of current literature
por: Alam-mehrjerdi, Zahra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h1ur5lbj81sjvh6lm1rqt4phcj